These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28364994)

  • 41. [Polypharmacy - Solutions for Enhanced Drug Safety].
    Krause O; Picksak G; Junius-Walker U
    Dtsch Med Wochenschr; 2017 Jul; 142(14):1046-1053. PubMed ID: 28728199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stemming the Rising Tide of Drug Burden.
    Edward Davidson H
    Consult Pharm; 2016 Nov; 31(11):612. PubMed ID: 28107117
    [No Abstract]   [Full Text] [Related]  

  • 43. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
    Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
    Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conflicts and concordance between measures of medication prescribing quality.
    Steinman MA; Rosenthal GE; Landefeld CS; Bertenthal D; Sen S; Kaboli PJ
    Med Care; 2007 Jan; 45(1):95-9. PubMed ID: 17279026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polypharmacy in older adults with cancer undergoing radiotherapy: A review.
    Novak J; Goldberg A; Dharmarajan K; Amini A; Maggiore RJ; Presley CJ; Nightingale G
    J Geriatr Oncol; 2022 Jul; 13(6):778-783. PubMed ID: 35227626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of drug-related problems in older polypharmacy primary care patients.
    Kovačević SV; Miljković B; Ćulafić M; Kovačević M; Golubović B; Jovanović M; Vučićević K; de Gier JJ
    J Eval Clin Pract; 2017 Aug; 23(4):860-865. PubMed ID: 28370742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model to minimize inappropriate medications in the elderly.
    Regal P
    Am J Med; 2013 Feb; 126(2):e9. PubMed ID: 23331457
    [No Abstract]   [Full Text] [Related]  

  • 48. Off-Label Prescribing and Polypharmacy: Minimizing the Risks.
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 Feb; 55(2):17-22. PubMed ID: 28218925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge.
    Hudhra K; García-Caballos M; Casado-Fernandez E; Jucja B; Shabani D; Bueno-Cavanillas A
    J Eval Clin Pract; 2016 Apr; 22(2):189-93. PubMed ID: 26399173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2017 May; 33(2):205-223. PubMed ID: 28364992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Polypharmacy in the elderly - choosing wisely by using the FORTA list].
    Wehling M; Throm C
    Dtsch Med Wochenschr; 2015 Sep; 140(18):1378-82. PubMed ID: 26360952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting.
    Zarowitz BJ; Stebelsky LA; Muma BK; Romain TM; Peterson EL
    Pharmacotherapy; 2005 Nov; 25(11):1636-45. PubMed ID: 16232025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inappropriate medication use among Chilean older people].
    Passi A; Margozzini P; Valenzuela E; Hoyl T; Marín PP; Carrasco M; Olea R; Gac H
    Rev Med Chil; 2016 Apr; 144(4):417-25. PubMed ID: 27401372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Polypharmacy--activities of the social insurance in Austria].
    Keuerleber S; Sauermann R
    Wien Med Wochenschr; 2016 Apr; 166(5-6):173-8. PubMed ID: 26847442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic.
    Patel T; Milligan J; Lee J
    J Spinal Cord Med; 2017 Jan; 40(1):54-61. PubMed ID: 26446538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines.
    Garattini S; Bertele' V
    Eur J Clin Pharmacol; 2018 Mar; 74(3):373-375. PubMed ID: 29181699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asthma management programs in managed care organizations.
    Hartmann CW; Maio V; Goldfarb NI; Cobb N; Nash DB
    Dis Manag; 2005 Dec; 8(6):339-45. PubMed ID: 16351552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer.
    Park JW; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2016 May; 142(5):1031-40. PubMed ID: 26744323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introduction of the Pill Pruner to acute medical care: a simple medication guide to control polypharmacy.
    Chieng JH; Hughes L; Stewart A; Frampton CM; Hanger HC; Jardine DL
    Australas J Ageing; 2015 Mar; 34(1):58-61. PubMed ID: 25582847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of drug-related problems in three departments of a German University hospital.
    Lenssen R; Heidenreich A; Schulz JB; Trautwein C; Fitzner C; Jaehde U; Eisert A
    Int J Clin Pharm; 2016 Feb; 38(1):119-26. PubMed ID: 26511945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.